Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Cadmium, road dust and rheumatoid arthritis: an alternative hypothesis to general air pollution *

We read the review “Is air pollution a risk factor for rheumatoid arthritis?” with great interest. We agree that air pollution is a potential risk factor for rheumatoid arthritis (RA) in low-and-middle-income countries. As the authors correctly point out, epidemiological studies in high-income countries which have failed to demonstrate a link between air pollution and the risk of RA, can not necessarily be generalised to individuals living in low-and-middle-income countries.

However, it remains that two large well conducted studies in North America have clearly demonstrated an increased risk of RA in those residing ≤ 50 m from a highway compared with residence > 150 m away. This finding is not explained by industrial pollution per se as two studies in high income countries found no consistent association between air pollution and an increased RA risk. If air pollution in high-income countries is not associated with the development of RA, what other factor can explain the risk for RA living in close proximity to a main road as opposed to just 150–200 m further away? We suggest a novel hypothesis of cadmium-containing road dust inhalation either by the roadside or within the home as a plausible explanation.

The lung is now considered to be an important initiating site of seropositive RA as a result of local anti-citrullinated peptide (anti-CCP) antibody generation. Inhalation of cadmium has been hypothesised as a potential trigger for RA as cadmium links smoking, the most important etiological factor in the development of seropositive RA, and many of the other known contemporary risk factors such as low socio-economic class, regional clustering in the U.S. and specific occupations associated with RA. Increased cadmium exposure in an animal model has recently been demonstrated to enhance disease activity of collagen induced arthritis.

Cadmium levels have been shown to markedly decrease within 20 m from the roadside. Cadmium is a component of petrol and diesel fuel and was previously used as a curing agent in tires, a component of brake pads, alloyed with copper in the production of car radiators and in car paints. Additionally, asphalt concrete road surfacing contains appreciable amounts of cadmium. We suggest that cadmium-laden ultrafine dust will occur in close proximity to busy roads as a result of both vehicular component and road surface wear, and vehicular fuel emissions. This would be particularly evident on fast moving roads where acceleration and hard braking is commonplace.

A number of nanoparticles, including silica, can induce lung citrullination via activation of cellular calcium channels with a subsequent rise in intracellular calcium and activation of peptidyl arginine deiminase and subsequent peptide citrullination. Fine cadmium dusts have the potential to cause citrullination as cadmium is a potent activator of calcium channels and significantly raises intracellular calcium levels.

Cadmium levels need not correlate with air pollution per se. This is exemplified by a US study demonstrating the mean concentration of cadmium in the air of 28 US cities was found to correlate with mortality rates from hypertension and coronary heart disease although indices of air pollution did not correlate with mortality from hypertension and coronary heart disease.

We suggest that further studies investigating the link between residing close to a main road and RA development take into account bodily cadmium levels as a co-founding factor as it is known that inhalation of road dust containing cadmium correlates with increased bodily levels of cadmium.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 04-24-2017
Authors: Daniel Murphy and David Hutchinson